FDA NDC Directory · JSON-LD · Markdown

icosapent ethyl

NDC 70710-1738 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerZydus Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA217656
Dosage form / routeCAPSULE · ORAL
Active ingredientsICOSAPENT ETHYL (.5 g/1)
Marketing started20230804
Package count1

External sources

Source: openFDA. Public-domain (CC0).